Lluis M Mir Selected Research

lucifer yellow

4/2009

900 MHz modulated electromagnetic fields accelerate the clathrin-mediated endocytosis pathway.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lluis M Mir Research Topics

Disease

24	Neoplasms (Cancer) 01/2023 - 10/2003
6	Neoplasm Metastasis (Metastasis) 10/2017 - 12/2006
5	Melanoma (Melanoma, Malignant) 11/2017 - 04/2009
2	Prostatic Neoplasms (Prostate Cancer) 10/2017 - 01/2014
1	Spinal Cord Compression 01/2023
1	Wounds and Injuries (Trauma) 01/2021
1	Communicable Diseases (Infectious Diseases) 01/2014
1	Colonic Neoplasms (Colon Cancer) 01/2014
1	Fever (Fevers) 09/2013
1	Ductal Carcinoma 09/2012
1	Experimental Melanoma 08/2011
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2011
1	Hyperthermia 04/2008
1	Hypoxia (Hypoxemia) 12/2006
1	Carcinoma (Carcinomatosis) 12/2003

Drug/Important Bio-Agent (IBA)

7	Bleomycin (Blenoxane)FDA LinkGeneric 01/2023 - 10/2003
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 12/2003
3	Norisoprenoids (Irones)IBA 10/2017 - 01/2014
3	Odorant Receptors (Odorant Receptor)IBA 10/2017 - 01/2014
3	LigandsIBA 01/2017 - 09/2008
2	DNA (Deoxyribonucleic Acid)IBA 01/2016 - 09/2013
2	AntigensIBA 01/2014 - 09/2008
2	VaccinesIBA 01/2014 - 01/2014
2	Proteins (Proteins, Gene)FDA Link 08/2011 - 12/2006
1	CalciumIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021
1	Chemokine ReceptorsIBA 11/2017
1	Chimeric Antigen ReceptorsIBA 11/2017
1	galleinIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Immune Checkpoint InhibitorsIBA 01/2016
1	CytokinesIBA 01/2016
1	ORALIT (ORS)IBA 01/2014
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2014
1	CalreticulinIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 01/2014
1	HMGB1 Protein (HMG1)IBA 01/2014
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2014
1	DNA VaccinesIBA 01/2014
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2014
1	Peptides (Polypeptides)IBA 09/2013
1	C-Reactive ProteinIBA 09/2013
1	1-aminomethylphosphonic acidIBA 09/2013
1	type IV collagen alpha3 chain (Goodpasture antigen)IBA 03/2013
1	Cobalt-60IBA 09/2012
1	DisintegrinsIBA 08/2011
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 08/2011
1	IntegrinsIBA 08/2011
1	LuciferasesIBA 08/2011
1	Protein Isoforms (Isoforms)IBA 08/2011
1	Thrombospondin 1IBA 08/2011
1	ClathrinIBA 04/2009
1	lucifer yellowIBA 04/2009
1	CaveolinsIBA 04/2009
1	Interferon-gamma (Interferon, gamma)IBA 09/2008
1	Immunologic Adjuvants (Immunologic Adjuvant)IBA 09/2008
1	OligodeoxyribonucleotidesIBA 09/2008
1	CPG-oligonucleotideIBA 09/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008
1	Interferon-alpha (Interferon Alfa)IBA 04/2008
1	AngiopoietinsIBA 12/2006
1	ElementsIBA 08/2005

Therapy/Procedure

5	Therapeutics 01/2020 - 09/2008
4	Electrodes (Electrode) 01/2022 - 11/2007
3	Radiotherapy 01/2023 - 04/2008
2	Immunotherapy 11/2017 - 01/2016
2	Drug Therapy (Chemotherapy) 04/2008 - 02/2007
1	Intraperitoneal Injections 10/2017
1	Palliative Care (Palliative Therapy) 01/2016
1	Aftercare (After-Treatment) 08/2011
1	Heterologous Transplantation (Xenotransplantation) 01/2011